ε-Sarcoglycan, a Broadly Expressed Homologue of the Gene Mutated in Limb-Girdle Muscular Dystrophy 2D*

The sarcoglycans are transmembrane components of the dystrophin-glycoprotein complex, which links the cytoskeleton to the extracellular matrix in adult muscle fibers. Mutations in all four known sarcoglycan genes (α, β, γ, and δ) have been found in humans with limb-girdle muscular dystrophy. We have identified a novel protein, ε-sarcoglycan, that shares 44% amino acid identity with α-sarcoglycan (adhalin). We show that ε-sarcoglycan is a membrane-associated glycoprotein and document its expression by Northern blotting, immunoblotting, and immunofluorescence. In contrast to α-δ sarcoglycans, which are expressed predominantly or exclusively in striated muscle, ε-sarcoglycan is broadly distributed in muscle and nonmuscle cells of both embryos and adults. These results raise the possibility that sarcoglycan-containing complexes mediate membrane-matrix interactions in many cell types.

[1]  Susan C. Brown,et al.  Utrophin-Dystrophin-Deficient Mice as a Model for Duchenne Muscular Dystrophy , 1997, Cell.

[2]  J. Sanes,et al.  Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy , 1997, Cell.

[3]  T. Freeman,et al.  Expression of the dystrophin-related protein 2 (Drp2) transcript in the mouse. , 1997, Journal of molecular biology.

[4]  E. Engvall,et al.  Mouse adhalin: primary structure and expression during late stages of muscle differentiation in vitro. , 1997, Biochemical and biophysical research communications.

[5]  C. de Toma,et al.  Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D). , 1997, Journal of medical genetics.

[6]  K. Daniels,et al.  Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. , 1997, Human molecular genetics.

[7]  K. Campbell,et al.  A Role of Dystroglycan in Schwannoma Cell Adhesion to Laminin* , 1997, The Journal of Biological Chemistry.

[8]  L. Kunkel,et al.  Dystrophies and heart disease. , 1997, Current opinion in cardiology.

[9]  K. Campbell,et al.  Transient expression of Dp140, a product of the Duchenne muscular dystrophy locus, during kidney tubulogenesis. , 1997, Developmental biology.

[10]  J. McPherson,et al.  Characterization of δ-Sarcoglycan, a Novel Component of the Oligomeric Sarcoglycan Complex Involved in Limb-Girdle Muscular Dystrophy* , 1996, The Journal of Biological Chemistry.

[11]  E. Hoffman,et al.  Autosomal recessive muscular dystrophy and mutations of the sarcoglycan complex , 1996, Neuromuscular Disorders.

[12]  L. Kunkel,et al.  The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. , 1996, Human molecular genetics.

[13]  K. Davies,et al.  Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene , 1996, Nature.

[14]  J. Ervasti,et al.  A new model for the interaction of dystrophin with F-actin , 1996, The Journal of cell biology.

[15]  K. Campbell,et al.  Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. , 1996, Current opinion in cell biology.

[16]  M. Passos-Bueno,et al.  Autosomal recessive limbgirdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ–sarcoglycan gene , 1996, Nature Genetics.

[17]  Y. Iwata,et al.  Expression of a dystrophin-sarcoglycan complex in serum-deprived BC3H1 cells and involvement of alpha-sarcoglycan in substrate attachment. , 1996, Biochemical and biophysical research communications.

[18]  G. Viglietto,et al.  Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. , 1996, Human molecular genetics.

[19]  M. F. Peters,et al.  Isoform Diversity of Dystrobrevin, the Murine 87-kDa Postsynaptic Protein (*) , 1996, The Journal of Biological Chemistry.

[20]  K. Campbell,et al.  Absence of γ‐sarcoglycan (35 DAG) in autosomal recessive muscular dystrophy linked to chromosome 13q12 , 1996, FEBS letters.

[21]  B. Brambati,et al.  Developmental expression of dystrophin, dystrophin-associated glycoproteins and other membrane cytoskeletal proteins in human skeletal and heart muscle. , 1996, Brain research. Developmental brain research.

[22]  D. Blake,et al.  Utrophin: A Structural and Functional Comparison to Dystrophin , 1996, Brain pathology.

[23]  K. Ohlendieck,et al.  Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers. , 1996, European journal of cell biology.

[24]  L. Kunkel,et al.  Mutations in the Dystrophin-Associated Protein γ-Sarcoglycan in Chromosome 13 Muscular Dystrophy , 1995, Science.

[25]  L. Kunkel,et al.  β–sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex , 1995, Nature Genetics.

[26]  K. Campbell,et al.  Dystroglycan expression in the wild type and mdx mouse neural retina: Synaptic colocalization with dystrophin, dystrophin‐related protein but not laminin , 1995, Journal of neuroscience research.

[27]  D. Górecki,et al.  Dystroglycan mRNA expression during normal and mdx mouse embryogenesis: A comparison with utrophin and the apo‐dystrophins , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[28]  K. Campbell,et al.  Dystrophin-glycoprotein complex: molecular organization and critical roles in skeletal muscle. , 1995, Current opinion in neurology.

[29]  O. Ibraghimov-Beskrovnaya,et al.  Non-muscle alpha-dystroglycan is involved in epithelial development , 1995, The Journal of cell biology.

[30]  S. Roberds,et al.  Laminin abnormality in severe childhood autosomal recessive muscular dystrophy. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[31]  J. Beckmann,et al.  Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy , 1994, Cell.

[32]  K. Campbell,et al.  Abnormal expression of laminin suggests disturbance of sarcolemma-extracellular matrix interaction in Japanese patients with autosomal recessive muscular dystrophy deficient in adhalin. , 1994, The Journal of clinical investigation.

[33]  K. Campbell,et al.  Expression of dystrophin-associated glycoproteins during human fetal muscle development: A preliminary immunocytochemical study , 1994, Neuromuscular Disorders.

[34]  H. Yamamoto,et al.  Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside. , 1994, European journal of biochemistry.

[35]  S. Froehner,et al.  Association of utrophin and multiple dystrophin short forms with the mammalian M(r) 58,000 dystrophin-associated protein (syntrophin). , 1994, The Journal of biological chemistry.

[36]  O. Ibraghimov-Beskrovnaya,et al.  Primary structure and muscle-specific expression of the 50-kDa dystrophin-associated glycoprotein (adhalin). , 1993, The Journal of biological chemistry.

[37]  L. Kunkel,et al.  The structural and functional diversity of dystrophin , 1993, Nature Genetics.

[38]  O. Ibraghimov-Beskrovnaya,et al.  Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix , 1992, Nature.

[39]  J. Ervasti,et al.  Membrane organization of the dystrophin-glycoprotein complex , 1991, Cell.

[40]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[41]  G. Heijne A new method for predicting signal sequence cleavage sites. , 1986 .

[42]  M. Kozak Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes , 1986, Cell.

[43]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .